The only notable difference was seen in patients with higher expression of mRNA level of lgals1. These patients had a significantly lower (p = 0.016) DFS than patients with negative/low levels of lgals1, consistent with previous observations that galectin-1 expression correlates with a poor prognosis in breast cancer [16]. The gene discussed is LGALS1; the disease is breast cancer.